Genflow Biosciences Statements
WQ
Data from Genflow Biosciences`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
GBP - British pound
Last reporting period:
30 Jun, 2023
Next reporting period:
27 Dec, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Genflow Biosciences Income Statement
B
M
GBP (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
0.415
0
0.4
0
0.621
-2.7 %
0
-0.621
2.7 %
0
0
0
—
0
-0.622
-10.7 %
0
—
0
-0.622
-10.7 %
0
-0.002
292.51
—
—
100
—
0
—
—
0
—
0
1.126
0
0.639
-17.4 %
0
-0.639
17.4 %
0
0
0
0.077
0
-0.562
27.4 %
0
—
0
-0.562
27.4 %
0
-0.002
295.16
—
—
100
—
0
—
—
0
—
0
0.696
0
0.773
6.8 %
0
-0.773
-6.8 %
0
0
0
—
0
-0.774
-7.1 %
0
—
0
-0.774
-7.1 %
0
-0.003
289.86
—
—
100
—
0
—
—
0
—
0
0.674
0
0.724
174.3 %
0
-0.724
-174.3 %
0
0.001
0
—
0
-0.723
-172.1 %
0
—
0
-0.723
-172.1 %
0
-0.018
40.833
—
—
100
—
0
—
—
0
—
0
0.264
0
0.264
—
0
-0.264
—
0
-0.002
0
—
0
-0.266
—
0
—
0
-0.266
—
0
-0.001
292.51